Search Results - Xavier Charmetant

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm by Xavier Charmetant, Xavier Charmetant, Xavier Charmetant, Gavin J. Pettigrew, Olivier Thaunat, Olivier Thaunat, Olivier Thaunat

    Published in Transplant International (2024-11-01)
    Get full text
    Article


  2. 2

    Late lymphocele infection with Parvimonas micra in a kidney allograft recipient by Rihab Dkhissi, Gabriel Ouellet, Xavier Charmetant, Fanny Buron, Florent Valour, Olivier Rouviere, Xavier Matillon, Emmanuel Morelon

    Published in BMC Infectious Diseases (2025-03-01)
    Get full text
    Article


  3. 3

    Reversible Glomerular Thrombotic Microangiopathy Associated With Nintedanib in a Kidney Transplant Recipient by Gabriel Ouellet, Cécile Picard, Maud Rabeyrin, Fanny Buron, François Lestelle, Julie Bellière, Alice Koenig, Olivier Thaunat, Emmanuel Morelon, Xavier Charmetant

    Published in Kidney International Reports (2025-06-01)
    Get full text
    Article


  4. 4

    γδ T Cells’ Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models by Xavier Charmetant, Xavier Charmetant, Xavier Charmetant, Guillaume Rigault, Chien-Chia Chen, Hannah Kaminski, Hannah Kaminski, Jonathan Visentin, Jonathan Visentin, Benjamin Taton, Gabriel Marseres, Virginie Mathias, Alice Koenig, Alice Koenig, Alice Koenig, Thomas Barba, Thomas Barba, Thomas Barba, Pierre Merville, Pierre Merville, Stéphanie Graff-Dubois, Emmanuel Morelon, Emmanuel Morelon, Emmanuel Morelon, Julie Déchanet-Merville, Valérie Dubois, Jean-Paul Duong van Huyen, Lionel Couzi, Lionel Couzi, Olivier Thaunat, Olivier Thaunat, Olivier Thaunat

    Published in Transplant International (2025-01-01)
    Get full text
    Article


  5. 5

    BK Virus: Beyond Nephropathy Metastatic BK Virus-Induced, Donor-Derived Bellini’s Carcinoma in a Kidney Allograft Recipient: Boosting Rejection to Treat the Cancer by Flora Lefevre, Mélanie Benoit-Janin, Emilien Seizilles-de-Mazancourt, Xavier Matillon, Fanny Buron, Alice Koenig, Valérie Dubois, Matthieu Dietz, Olivier Rouvière, Emmanuel Morelon, Olivier Thaunat, Xavier Charmetant

    Published in Transplant International (2025-07-01)
    Get full text
    Article


  6. 6

    Hamster organotypic kidney culture model of early-stage SARS-CoV-2 infection highlights a two-step renal susceptibility by Sophie R Shyfrin, Marion Ferren, Laure Perrin-Cocon, Maxime Espi, Xavier Charmetant, Manon Brailly, Didier Decimo, Mathieu Iampietro, Lola Canus, Branka Horvat, Vincent Lotteau, Pierre-Olivier Vidalain, Olivier Thaunat, Cyrille Mathieu

    Published in Journal of Tissue Engineering (2022-09-01)
    Get full text
    Article


  7. 7

    Immune Checkpoint Inhibitors in Kidney Transplant Recipients: A French Multicenter Retrospective Cohort Study by Tristan Legris, MD, Marion Sallée, MD, PhD, Xavier Charmetant, MD, PhD, Olivier Thaunat, MD, PhD, Marie Matignon, MD, PhD, Nizar Joher, MD, Vincent Pernin, MD, PhD, Antoine Sicard, MD, PhD, Hannah Kaminski, MD, PhD, Lionel Couzi, MD, PhD, Valérie Moal, MD, PhD

    Published in Transplantation Direct (2025-09-01)
    Get full text
    Article


  8. 8

    Maximum cold ischemia duration for a kidney allograft: a prediction model for allograft failure at the time of organ allocationResearch in context by Clement Gosset, Susana Barbosa, Alexandre Destere, Sebastien Cuozzo, Laetitia Albano, Emmanuel Morelon, Xavier Charmetant, Moglie Le Quintrec, Jean-Emmanuel Serre, Marc Ladrière, Sophie Girerd, Christophe Masset, Dany Anglicheau, Carmen Lefaucheur, Gillian Divard, Enrico Gruden, Matthieu Durand, Dirk Kuypers, Maarten Coemans, Nicolas Glaichenaus, Oriol Bestard, Anders Åsberg, Magali Giral, Maarten Naesens, Antoine Sicard

    Published in EClinicalMedicine (2025-07-01)
    Get full text
    Article


Search Tools: